can you use fsa for compounded semaglutide Weight Loss by Patiently GLP-1 Semaglutide Rx | FancyMeds

Independent Wellnesss approach to microdosing stands out thanks to its next-level access to clinicians

Three cases occurred across 1,032 total trial participants

Month 6 to 9: Clinical trial data for semaglutide shows average weight loss of approximately 15% of body weight at 68 weeks when combined with lifestyle changes

Additionally, there is potential for functional interaction between incretin receptors and other GPCRs, including the SCFA-activated FFARs, to occur in the islets of Langerhans (as previously discussed), but also in the gut and the hypothalamus, all of which could influence incretin therapy responses